title: Demyelination in a patient receiving ustekinumab for refractory Crohn's disease.
authors.affiliation: CHU de Bordeaux, Hôpital Haut-Lévêque, Service d'Hépato-gastroentérologie, Univ. Bordeaux, Laboratoire de bactériologie, F-33000 Bordeaux, France.
authors.forename: Yaeesh
authors.initials: Y
authors.lastname: Badat
authors.affiliation: CHU de Bordeaux, Hôpital Pellegrin, Service de Neurologie, Univ. Bordeaux, Institut des Maladies Neurodégénératives, CNRS UMR 5293, F-33000 Bordeaux, France.
authors.forename: Wassilios G
authors.initials: WG
authors.lastname: Meissner
authors.affiliation: CHU de Bordeaux, Hôpital Haut-Lévêque, Service d'Hépato-gastroentérologie, Univ. Bordeaux, Laboratoire de bactériologie, F-33000 Bordeaux, France. Electronic address: david.laharie@chu-bordeaux.fr.
authors.forename: David
authors.initials: D
authors.lastname: Laharie
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use; D003424:Crohn Disease / Q000175:diagnosis / Q000188:drug therapy*; D003711:Demyelinating Diseases / Q000139:chemically induced* / Q000175:diagnosis; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D012189:Retrospective Studies; D000069549:Ustekinumab
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000069549:Ustekinumab